Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptid
KALRN
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5513046
Kurzübersicht für Kalirin, RhoGEF Kinase (KALRN) (Middle Region) Peptid (ABIN5513046)
Target
KALRN
(Kalirin, RhoGEF Kinase (KALRN))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- GRKSFDLGSP KPGDETTPQG DSADEKSKKG WGEDEPDEES HTPLPPPMKI
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- KALRN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- KALRN (Kalirin, RhoGEF Kinase (KALRN))
-
Hintergrund
-
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described.
Alias Symbols: DUO, CHD5, DUET, TRAD, CHDS5, HAPIP, ARHGEF24
Protein Size: 738 -
Gen-ID
- 8997
-
NCBI Accession
- NM_001024660, NP_001019831
Target
-
Sie sind hier:
